SEC Form 4 research

NRX Pharmaceuticals, Inc. insider transactions

Recent insider disclosures

No matching recent records; this is not a statement about historical activity.

Officers and directors in the directory

• Gorovitz Aaron — 1 qualifying
• Willard Stephen H — 3 qualifying
• Hurvitz Chaim — 4 qualifying
• VAN VOORHEES SETH — 25 qualifying
• Flynn Patrick John — 5 qualifying
• ACKERMAN RICHARD — 2 qualifying
• Besthof Robert — 1 qualifying
• Big Rock Partners Sponsor, LLC — 2 qualifying
• Daigneault Alessandra — 1 qualifying
• Javitt Jonathan C — 6 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.